CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,242,000 | +105.5% | 43,399 | -1.4% | 0.07% | +112.9% |
Q2 2022 | $1,091,000 | -2.0% | 44,024 | -0.9% | 0.03% | +19.2% |
Q1 2022 | $1,113,000 | -55.4% | 44,407 | -35.2% | 0.03% | -50.9% |
Q4 2021 | $2,493,000 | +90.0% | 68,480 | -10.7% | 0.05% | +82.8% |
Q3 2021 | $1,312,000 | -13.7% | 76,704 | +212.3% | 0.03% | -14.7% |
Q4 2020 | $1,521,000 | +11.9% | 24,562 | -1.0% | 0.03% | -12.8% |
Q3 2020 | $1,359,000 | -5.5% | 24,803 | -0.8% | 0.04% | -7.1% |
Q2 2020 | $1,438,000 | +43.4% | 24,997 | +0.1% | 0.04% | +13.5% |
Q1 2020 | $1,003,000 | – | 24,970 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |